文献速递生殖医学

复发性妊娠丢失与不明原因不孕患者子宫免疫系统的无活检分析

Biopsy-free profiling of the uterine immune system in patients with recurrent pregnancy loss and unexplained infertility.
PubMed 文献 · Reprod Biomed Online · 2023-03-29

前瞻性研究纳入46例健康对照、28例复发性妊娠丢失(RPL)和11例不明原因不孕(uINF)患者,比较月经血与子宫内膜活检的淋巴细胞组成,并用流式细胞术分析外周血和月经血。RPL患者月经血CD56+ NK细胞显著高于对照,RPL和uINF患者CD56dimCD16bright NK细胞降低,uINF患者CD3+ T细胞最低且NKp46、NKG2D表达升高。

要点

  • 月经血第一24小时可反映子宫内膜免疫环境。
  • RPL患者月经血CD56+ NK细胞高于对照。
  • RPL和uINF患者月经血NK细胞亚型分布改变,提示细胞毒性改变。

核心结论

  • 与对照相比,RPL和uINF患者月经血NK细胞亚型谱不同,提示细胞毒性改变。
  • 未来研究可能通过这种无创分析识别和监测接受免疫调节药物的患者。

研究设计与样本

  • 前瞻性研究纳入46例健康对照、28例RPL和11例uINF患者。
  • 可行性研究在7例对照中比较子宫内膜活检与月经第一48小时采集的月经血淋巴细胞组成。
  • 所有患者的外周血和第一及后续24小时月经血分别用流式细胞术分析,聚焦主要淋巴细胞群和NK细胞亚群。

主要发现

  • RPL患者月经血CD56+ NK细胞数量显著高于对照(均值±标准差:31.13±7.52% vs 36.73±5.4%,P=0.002)。
  • 月经血CD56dimCD16bright NK细胞在CD56+ NK细胞群中,RPL患者为16.34±14.65%(P=0.011),uINF患者为15.7±5.91%(P=0.02),均低于对照的20.42±11.53%。
  • uINF患者月经血CD3+ T细胞计数最低(38.81±5.04%,对照 vs uINF:P=0.01)。
  • uINF患者CD56brightCD16dim细胞上细胞毒性受体NKp46和NKG2D高于对照(分别为68.12±11.84%,P=0.006;45.99±13.83%,P=0.01),RPL患者NKp46为66.21±15.36%(P=0.009)。
  • RPL和uINF患者外周血CD56+ NK细胞计数高于对照(分别为11.42±4.05%,P=0.021;12.86±4.29%,P=0.009 vs 8.4±3.5%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: What are the differences in menstrual blood lymphocytes between controls, patients with recurrent pregnancy loss (RPL) and patients with unexplained infertility (uINF)? DESIGN: Prospective study including 46 healthy controls, 28 RPL and 11 uINF patients. A feasibility study compared lymphocyte compositions of endometrial biopsies and menstrual blood collected during the first 48 h of menstruation in seven controls. In all patients, peripheral and menstrual blood from the first and subsequent 24 h were analysed separately by flow cytometry, focusing on the main lymphocyte populations and natural killer (NK) cell subsets. RESULTS: The first 24 h of menstrual blood resembles the uterine immune milieu as tested by endometrial biopsy. RPL patients showed significantly higher menstrual blood CD56+ NK cell numbers than controls (mean ± SD: 31.13 ± 7.52% versus 36.73 ± 5.4%, P = 0.002). Menstrual blood CD56dimCD16bright NK cells within the CD56+ NK cell population were decreased in RPL (16.34 ± 14.65%, P = 0.011) and uINF (15.7 ± 5.91%, P = 0.02) patients versus control (20.42 ± 11.53%). uINF patients had the lowest menstrual blood CD3+ T cell counts (38.81 ± 5.04%, control versus uINF: P = 0.01) and cytotoxicity receptors NKp46 and NKG2D on CD56brightCD16dim cells were higher in uINF (68.12 ± 11.84%, P = 0.006; 45.99 ± 13.83%, P = 0.01, respectively) and RPL (NKp46: 66.21 ± 15.36%, P = 0.009) patients versus controls. RPL and uINF patients had higher peripheral CD56+ NK cell counts versus controls (11.42 ± 4.05%, P = 0.021; 12.86 ± 4.29%, P = 0.009 versus 8.4 ± 3.5%). CONCLUSIONS: Compared with controls, RPL and uINF patients had a different menstrual blood-NK-subtype profile, indicating an altered cytotoxicity. In future studies, this non-invasive analysis might enable identification and monitoring of patients receiving immunomodulatory medications.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Vomstein K, Egerup P, Kolte AM, et al. Biopsy-free profiling of the uterine immune system in patients with recurrent pregnancy loss and unexplained infertility. Reprod Biomed Online. 2023. PMID: 37211442. doi:10.1016/j.rbmo.2023.03.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。